ViroCell Biologics

ViroCell Biologics is a contract development and manufacturing organization (CDMO) specializing in the production of viral vectors and gene-modified cells. The company focuses on facilitating the advancement of novel cell and gene therapies into clinical trials. By providing a platform that ensures a rapid, safe, and reliable transition from laboratory research to clinical application, ViroCell Biologics aims to de-risk and enhance the value of cell and gene therapy innovations. This enables medical researchers to obtain the necessary gene-modified cells for their clinical studies, supporting the development of new treatments in the field of regenerative medicine.